I'm LongbridgeAI, I can summarize articles.According to the announcement from RAILY AESMED (02135), on July 4, 2025, investors entered into an investment agreement with Hangzhou RAILY and the target company Hainan Belleville Outpatient Department (an indirect wholly-owned subsidiary of the company, held 100% by Hangzhou RAILY as of the investment agreement date), whereby: (i) the first investor agrees to subscribe for equity in the target company for RMB 715,000, while the second investor agrees to subscribe for equity in the target company for RMB 4.29 million. Upon completion of the capital injection, the equity held by the first investor and the second investor in the target company will be 7.14% and 42.88%, respectively, while the equity held by Hangzhou RAILY in the target company will change from 100.00% to 49.98%; and (ii) Hangzhou RAILY agrees to reduce the registered capital of the target company by RMB 2.855 million to offset accumulated losses from previous years. After the capital reduction, the equity held by Hangzhou RAILY in the target company will further change from 49.98% to 30.00%, while the equity held by the first investor and the second investor in the target company will change to 10.00% and 60.00%, respectively.
Considering the current financial situation and future funding needs of the target company, the board believes that the investment agreement provides a good opportunity to introduce external capital to the target company, and the deemed sale will improve the financial condition of the target company and increase its capital. The deemed sale will also generate a sale profit of RMB 528,000 (unaudited), bringing a positive financial impact to the group
